CHARLES BIRBARA, M.D.
Specialist · WORCESTER, MA
Individual Active NPI 1093705410
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 416 | 232,564 | $4,852,558 | $2,311,772 | $1,826,287 |
| 2023 | 443 | 132,596 | $4,416,392 | $2,127,043 | $1,676,665 |
| 2022 | 455 | 122,347 | $4,637,658 | $2,122,280 | $1,668,291 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J1010 | Injection, methylprednisolone acetate, 1 mg | 101,602 | $0 | $0 |
| J3262 | Injection, tocilizumab, 1 mg | 71,520 | $6 | $5 |
| J7328 | Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg | 11,762 | $1 | $0 |
| J0897 | Injection, denosumab, 1 mg | 11,040 | $25 | $20 |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 10,230 | $29 | $23 |
| 20550 | Injection into tendon or ligament | 1,702 | $38 | $29 |
| J9260 | Injection, methotrexate sodium, 50 mg | 1,199 | $2 | $2 |
| Q5104 | Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | 1,030 | $31 | $23 |
| 20610 | Aspiration and/or injection of fluid from large joint | 969 | $61 | $46 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 820 | $0 | $0 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 774 | $6 | $4 |
| J9250 | Methotrexate sodium, 5 mg | 509 | $0 | $0 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Specialist | 174400000X | ✓ | 32425 | MA |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Specialist providers in Massachusetts
- NPI 1003220377
- NPI 1508817834
- NPI 1861587057
- NPI 1619959202
- NPI 1386852358
- NPI 1962408971
- NPI 1043433832
- NPI 1518916188
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.